Safety & Regulatory Standards

1. Non-Profit, Research-Only Mission

Nuri Clinic is a non-profit research organization, not a retail supplement brand or traditional medical practice.
Our programs are designed to study how certain modern tools may impact recovery, resilience, and metabolic health in adults who are already exploring these options.
Revenues are reinvested into:
- Research program costs
- Participant support and clinical oversight
- Educational resources and safety communications

‍

We are not here to push products. We are here to bring structure, ethics, and data into a space that has often been dominated by hype.

2. IRB Oversight and Ethical Governance

Nuri’s research protocols are governed by an FDA–HHS–approved Institutional Review Board (IRB).

What that means in practice:

Every research program is reviewed for:
- Risk vs. potential benefit
- Participant protections
- Informed consent language and process
The IRB can require changes, pause enrollment, or stop a program if concerns arise.
Our team is obligated to follow IRB-approved protocols and report any adverse events or serious safety issues.

‍

IRB oversight does not remove all risk, but it adds an important layer of independent ethical review that most peptide or “optimization” offerings do not have.

3. Experimental Status of Compounds

Many of the compounds used in Nuri’s programs — including various peptide and metabolic agents — are experimental in the contexts described and:

Are not approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease.
May not have large, long-term clinical trials in humans for the specific uses being studied.
Are used only within the structure of an IRB-governed research program, not as standard medical treatment.
‍

We commit to:

Clearly labeling experimental compounds in our materials.
Avoiding language that implies our programs are FDA-approved therapies or guaranteed treatments.
Updating this page if regulatory status or guidance changes.

‍

If you are looking for an FDA-approved treatment, Nuri is not the right fit. Our work is research, not standard of care.

4. Relationship to Your Existing Medical Care

Participation in a Nuri research program does not replace:

Your relationship with a primary care provider
Care from specialists (orthopedists, endocrinologists, etc.)
Emergency or urgent medical services

We strongly encourage:

Discussing potential participation in Nuri programs with your current healthcare providers.
Informing us about all medications, supplements, and relevant medical history during intake.
Keeping your usual medical appointments and screenings while enrolled.

Our clinicians focus on program eligibility, safety within the research protocol, and ongoing monitoring — not on replacing your full medical care team.

5. Participant Screening, Consent, and Oversight

Every Nuri program follows a structured process designed around safety:

Step 1 – Initial Screening Form

A brief online form screens for major disqualifiers and red flags (certain medical conditions, medications, pregnancy, etc.). If it appears that participation could be unsafe or inappropriate, we do not move forward.

Step 2 – Free Call With a Licensed Clinician

Eligible individuals can schedule a free call with a licensed clinician. This call is used to:

Understand your goals and history
Answer questions about the research program=
Decide whether participation is appropriate or whether we recommend other avenues

Step 3 – Comprehensive Medical Evaluation & Informed Consent

Before any protocol is shipped:

You complete a more detailed medical evaluation.
We walk through a thorough informed consent process that covers:
- Experimental status of the compounds
- Known and unknown risks and limitations
- Regulatory and sport-related considerations
- Your responsibilities during the program

‍

You are encouraged to ask questions and take time to decide.

Step 4 – At-Home Protocol With Ongoing Oversight

Once enrolled:

You follow a defined at-home research protocol.
You have access to our clinical team for questions, check-ins, and symptom reporting.
We monitor for potential side effects and can adjust, pause, or end participation if needed.

6. Sourcing and Quality Practices

We do not procure products from anonymous “research use only” websites or unverified international labs.

‍

Instead, we:

Work with carefully vetted domestic manufacturers or compounding channels appropriate for research use.
Expect these partners to adhere to strict quality and sterility standards.
Keep internal records of lot numbers and sourcing details for safety and traceability.

No system is perfect, but we take sourcing seriously and do not treat it as an afterthought.

7. Marketing and Claims Standards

In all public content — including our website, emails, and educational materials — we commit to the following:

We will not claim that our programs:
- Cure disease
- Guarantee specific outcomes
- Replace surgery or medical treatment
We will not describe experimental compounds as:
- “Proven cures”
- “Miracle” solutions
- Safe for everyone
We will do our best to:
- Use plain, conservative language about what is known and unknown
- Distinguish clearly between research observations, early evidence, and established science
- Correct or clarify any overstated claims we discover in our own materials

If you ever see language from Nuri that feels inconsistent with these standards, we invite you to let us know so we can review and update it.

8. Considerations for Athletes and Anti-Doping Rules

Certain compounds that may appear in Nuri research programs may be prohibited in competitive sports under anti-doping rules.

It is each participant’s responsibility to understand and comply with the rules of their sport, federation, or organization.
We encourage competitive athletes to:
- Disclose their status during intake
- Review relevant anti-doping rules before enrolling
- Speak with their coaches or governing bodies if they have questions

If we believe a program is likely to conflict with known anti-doping rules, we will discuss that openly and may advise against participation.

9. Data, Privacy, and Use of Research Information

Because Nuri operates as a research organization:

We collect data on:
- Eligibility and demographics
- Self-reported outcomes and experiences
- Side effects or adverse events
Data is handled in accordance with:
- IRB-approved protocols
- Applicable privacy laws and our internal privacy policy

We may use de-identified or aggregated data:

To improve program safety and design
For internal reporting and planning
For future publications, presentations, or educational materials

We do not sell participant data as a standalone product.

10. Continuous Review and Updates

The regulatory landscape for peptides and other emerging tools is evolving.